Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Etiologies and sequelae of extreme thrombocytosis in a large pediatric hospital

View ORCID ProfileChristopher S Thom, Emily Echevarria, Ashley D Osborne, Leah Carr, Kathryn Rubey, Elizabeth Salazar, Danielle Callaway, Thomas Pawlowski, Matt Devine, Stacey Kleinman, John Flibotte, Michele P Lambert
doi: https://doi.org/10.1101/2020.06.01.20119438
Christopher S Thom
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher S Thom
  • For correspondence: thomc@email.chop.edu
Emily Echevarria
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley D Osborne
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Carr
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Rubey
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Salazar
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Callaway
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Pawlowski
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matt Devine
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Kleinman
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Flibotte
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
2Division of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele P Lambert
1Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
3Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Extreme thrombocytosis (ET, platelet count >1000 × 103/ul) is an uncommon clinical finding 1. Primary ET is associated with myeloproliferative disorders, such as essential thrombocythemia 2. Secondary ET is more common and occurs in reaction to infection, inflammation, or iron deficiency. Bleeding and thrombotic complications more frequently arise in primary ET cases 1, but have been reported with secondary ET in adults 3. Etiologies and complications associated with ET in children are less well-defined, as prior pediatric studies have been relatively small or restricted to specialized patient populations 4,5. We aimed to characterize ET in a large, single-center pediatric cohort.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a grant from the National Institutes of Health, USA (T32HD043021 to CST), an American Academy of Pediatrics Marshall Klaus Neonatal-Perinatal Research Award (CST), and the Childre’s Hospital of Philadelphia Division of Neonatology.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Date: May 01, 2020 To: John Flibotte CC: Christopher Thom From: The Committees for the Protection of Human Subjects (IRB) Re: IRB 20-017443, Protocol Title: Evaluating causes and syndromes associated with extreme pediatric thrombocytosis (extremey high platelet counts). Sponsor or Funder: Children’s Hospital of Philadelphia, The (CHOP) IRB SUBMISSION: EXEMPTION GRANTED

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

De-identified summary data will be made available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 02, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Etiologies and sequelae of extreme thrombocytosis in a large pediatric hospital
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Etiologies and sequelae of extreme thrombocytosis in a large pediatric hospital
Christopher S Thom, Emily Echevarria, Ashley D Osborne, Leah Carr, Kathryn Rubey, Elizabeth Salazar, Danielle Callaway, Thomas Pawlowski, Matt Devine, Stacey Kleinman, John Flibotte, Michele P Lambert
medRxiv 2020.06.01.20119438; doi: https://doi.org/10.1101/2020.06.01.20119438
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Etiologies and sequelae of extreme thrombocytosis in a large pediatric hospital
Christopher S Thom, Emily Echevarria, Ashley D Osborne, Leah Carr, Kathryn Rubey, Elizabeth Salazar, Danielle Callaway, Thomas Pawlowski, Matt Devine, Stacey Kleinman, John Flibotte, Michele P Lambert
medRxiv 2020.06.01.20119438; doi: https://doi.org/10.1101/2020.06.01.20119438

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5905)
  • Intensive Care and Critical Care Medicine (364)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (351)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)